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Abstract 
Background: Alizarin and purpurin are di- and trihydroxyanthraquinones derived from Rubia tinctorum L. Previous 
pharmacological studies have demonstrated that they exhibit certain degree of selective inhibitory effects towards 
cancer cells suggesting their application as a targeted drug for cancer. Our present work was aimed to investigate the 
suitability of hydroxyanthraquinones of Rubia tinctorum L. for targeted tumor therapy. The effects of alizarin, purpurin 
and an aqueous extract from transformed hairy root culture of Rubia tinctorum L. were examined on (1) cell prolifera-
tion, (2) apoptosis, (3) cell adhesion/morphology and (4) migration (chemotaxis, chemokinesis) of human melanoma 
cell lines (A2058, HT168-M1) and human fibroblast cells (MRC-5), as well as (5) the aqueous extract was analytically 
characterized.
Methods: The aqueous extract was prepared from R. tinctorum hairy root culture and qualitatively analyzed by HPLC 
and ESI–MS methods. The cell growth inhibitory activity of anthraquinones was evaluated by MTT-assay and by flow 
cytometry. The effect of anthraquinones on cell adhesion was measured by an impedance based technique, the xCEL-
Ligence SP. For the chemotaxis assay NeuroProbe® chamber was used. Computer based holographic microscopy was 
applied to analyze chemokinetic responses as well as morphometry. Statistical significance was determined by the 
one-way ANOVA test.
Results: In the aqueous extract, munjistin (Mr = 284, tR = 18.4 min) as a principal component and three minor anth-
raquinones (pseudopurpurin, rubiadin and nordamnacanthal) were identified. The purpurin elicited a stronger but not 
apoptosis-mediated antitumor effect in melanoma cells (A2058: 10−6–10−5 M: 90.6–64.1 %) than in normal fibroblasts 
(10−6–10−5 M: 97.6–84.8 %). The aqueous extract in equimolar concentrations showed the most potent cytotoxicity 
after 72 h incubation (A2058: 10−6–10−5 M: 87.4–55.0 %). All tested substances elicited chemorepellent effect in mela-
noma cells, while in MRC-5 fibroblasts, only the alizarin exhibited such a repellent character. Indices of chemokinesis 
measured by holographic microscopy (migration, migration directness, motility and motility speed) were significantly 
enhanced by alizarin and purpurin as well, while morphometric changes were weak in the two melanoma cell lines.
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Background
Common madder (Rubia tinctorum L.) is a well-known, 
traditional medicinal plant. It contains substantial 
amount of anthraquinones in its root and rhizome. The 
plant has been used to dye textiles and as food colorant in 
many parts of the world since ancient times. Furthermore 
the crude extract of Rubia has been used in folk medi-
cines as an anti-inflammatory, antibacterial and antifun-
gal agent [1], or for the treatment of bladder and kidney 
stones, especially those consisting of calcium oxalate and 
calcium phosphate in the urinary tract [2–4].
The pharmacologically important main components 
of Rubia tinctorum L. are di- and trihydroxyanthraqui-
nones: alizarin (Fig.  1a), purpurin (Fig.  1b) and their 
derivatives, ruberythric acid (alizarin-primeveroside), 
pseudopurpurin and lucidin-primeveroside [3]. Further-
more, several other anthraquinones were identified as 
munjistin, pseudopurpurin, nordamnacanthal and luci-
din [5, 6].
Several synthetic anthraquinones such as doxorubicin 
are one of the most effective agents for the treatment of 
different tumors in clinical practice; however, they have 
several drawbacks including lack of selectivity and con-
sequently toxicity to normal cells [7]. Selective and sig-
nificant antitumor actions could be achieved by direct 
inhibition of different tumor specific molecular targets 
(e.g. overexpressed receptors or biochemical processes). 
Application of drug delivery systems or drug targeting 
conjugates is another well-accepted strategy. In this case 
a delivery unit ensures the targeting and the internaliza-
tion of a drug furnished conjugate via its receptors over-
expressed on tumor cells [8–10].
In case of alizarin a selective cytostatic activity was 
reported towards primary bone cancers or tumors 
metastasized to bone by inhibiting the activation of ERK 
signaling and inducing cell cycle arrest in S phase [2]. 
Another study has reported the purpurin as an inhibitor 
of cell migration through blockade the leukotriene recep-
tor (LTB2 receptor of leukotriene B4 (LTB4)) induced 
signaling [11], which pathway was shown to involve in 
e.g. prostate, ovarian, breast tumor progression [12–14].
For analytical characterization of the anthraquinone 
constituents of Rubia tinctorum L. and investigation of 
their effects on melanoma cell proliferation, adhesion 
and migration, transformed root cultures were used in 
our work. The application of genetically modified hairy 
root cultures provides several advantages. These cultures 
are genetically stable, have the ability to grow rapidly on 
media containing no growth regulators, and their second-
ary metabolite production reaches that of the correspond-
ing plant or may exceed in some cases [15–17]. Previously 
we established a simple isocratic method to analyze the 
alizarin and purpurin contents of genetically transformed 
roots of Rubia tinctorum L. following an acidic hydrolysis 
[18]. One of the limitations of this acidic treatment is the 
possible formation of the mutagenic lucidin [19]. Derk-
sen and his co-workers described methods of aqueous 
hydrolysis by native enzymes, which resulted in a suspen-
sion containing pseudopurpurin, munjistin, alizarin and 
nordamnacanthal without the formation of lucidin [5, 6].
Based on the above mentioned findings [2, 11] it is 
assumed that these anthraquinones or other compo-
nents of Rubia extracts could be exploited for inhibition 
of tumor growth and progression as well as for design 
drug components of conjugates used in targeted tumor 
therapy.
In this present work the above described method of 
aqueous hydrolysis was applied to qualitatively charac-
terize the anthraquinone contents of genetically trans-
formed root cultures of Rubia tinctorum L. by HPLC and 
ESI–MS methods. The effects of the aqueous extract on 
the cell physiological responses (proliferation, cell adhe-
sion/morphology and migration) in human cell lines 
representatives of metastatic tumors (melanomas) and a 
normal fibroblast model cell were investigated and com-
pared to the activity of alizarin and purpurin. We aimed 
to evaluate tumor selective actions of Rubia-derived 
anthraquinones and to find an antiproliferative/cytotoxic 
anthraquinone as a drug component in a potential drug 
delivery system.
Conclusions: Our results highlight the effective and selective inhibitory activity of purpurin towards melanoma cells 
and its possible use as a targeted anticancer agent. The anthraquinones of the cytotoxic extract are suggested to 
apply in drug delivery systems as an anticancer drug.
Keywords: Rubia tinctorum L., Hydroxyanthraquinone, Purpurin, Melanoma, Targeted therapy, HPLC–MS/MS, Cell 
adhesion, Migration, Impedimetry, Holographic microscope
Fig. 1 Chemical structure of the a alizarin and b purpurin
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Results
Qualitative determination of the extract
The authentic standards alizarin and purpurin as well as 
the purified aqueous extract of Rubia tinctorum L. were 
analyzed by LC–MS/MS method (Fig. 2). Assuming that 
the anthraquinones of the extract ionize like the anth-
raquinone standards, the base peaks would correspond 
with the [M–H]¯ ions. For all of the studied anthraqui-
nones, a loss of 28 amu was observed, corresponding to 
a loss of CO. In two cases a loss of 44 amu was detected, 
which agreed with the decarboxylation of the parent 
ion [M–H–CO2]¯. The data obtained were compared 
with data from literature [20, 21]. From this compari-
son, four peaks were tentatively identified as pseudopur-
purin (Mr =  300, tR =  16.1  min), munjistin (Mr =  284, 
tR = 18.4 min), rubiadin (Mr = 254, tR = 19.8 min) and 
nordamnacanthal (Mr = 268, tR = 21.0 min) (Fig. 3).
Antiproliferative/cytotoxic effects
To determine the long term antiproliferative/cytotoxic 
effect of alizarin, purpurin and the aqueous extract the 
cells were treated with the compounds for 48 and 72 h. 
The most significant effects could be observed after 72 h; 
therefore, only the results of the 72 h long treatments are 
presented below, and shown in Fig.  4, while the data of 
the 48  h long incubation are given in Additional file  1: 
Figure S1.
Seeding 104 cells/well in a 96-well plate formed non-
confluent layer after 24  h of culturing when the treat-
ment occurred. In case of the cytotoxicity experiments, 
the cells were in the logarithmic phase of growth at the 
treatment.
The alizarin elicited a slight, but significant prolif-
eration inducer effects in both melanoma cell lines with 
the same activity in 10−7–10−5 M range (A2058: 106.8–
113.2  %, p  <  0.05; HT168-M1: 107.9–109.3  %, p  <  0.05) 
(Fig.  4a). In contrast, an inhibitory character of alizarin 
was shown in MRC-5 cells after 72 h in 10−7 M concen-
tration (89.7 %, p < 0.01) (Fig. 4a).
The purpurin displayed a concentration and time 
dependent growth inhibitory effect in A2058 cells (10−6–
10−5 M: 90.6–64.1 %, p < 0.001) (Fig. 4b). A weaker inhib-
itory effect of purpurin was detected in HT168-M1 cell 
line. Interestingly, this compound decreased the number 
of HT168-M1 cells both in the lowest (10−8 M: 89.3  %, 
p  <  0.05) and highest concentration (10−5 M: 76.2  %, 
Fig. 2 ESI-MS spectra of the anthraquinones identified in the aqueous extract of Rubia tinctorum L.
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p  <  0.001) tested in this experiment. In case of MRC-5 
normal cells the purpurin displayed lower antiprolifera-
tive/cytotoxic effect than in melanoma cell lines and it 
was shown only in 10−5 M (84.8 %, p < 0.001) (Fig. 4b).
The treatment with the aqueous extract exhibited a 
strong decrease in the number of melanoma cells in 
10−6–10−5 M concentration range, which activity was 
demonstrated already after 48  h (Additional file  1: Fig-
ure S1c). This inhibitory effect was more pronounced in 
A2058 (10−6–10−5 M: 87.4–55.0  %, p  <  0.001) than in 
HT168-M1 cells (10−6–10−5 M: 87.5–63.7 %, p < 0.001) 
after 72  h (Fig.  4c). In MRC-5 cells a similar, concen-
tration dependent antiproliferative/cytotoxic effect 
(10−6–10−5 M: 77.2–62.0 %, p < 0.001) was observed for 
this aqueous extract (Fig. 4c).
The effect of short term treatment (6 h) with the anth-
raquinones was also examined. The antiproliferative/
cytotoxic effect of the compounds was detected by MTT-
assay after washing out the substances from the cells and 
a further 72 h of culturing. In this experiment, the most 
effective concentrations (10−6, 10−5 M) of the long term 
cytotoxicity study were used. The results of the short 
term growth inhibitory effect are presented in Table 1.
The alizarin proved to be neutral on the prolif-
eration of all model cells. The purpurin significantly 
reduced the number of melanoma cells but only at 10−5 
Fig. 3 HPLC total ion chromatogram of the aqueous extract of Rubia tinctorum L.
Fig. 4 Long term growth inhibitory effects of a alizarin, b purpurin and c aqueous extract. Two different melanoma cell lines (A2058 and HT168-
M1) and normal fibroblast cells (MRC-5) were applied as model cells and were incubated with the anthraquinones for 72 h. The ‘Inhibition index’ 
(Inh. ind.) is expressed as a percentage of the control. Data shown in the figure represent mathematical averages of six parallels and ± S.D. values. 
The level of significance is shown as follows: *p < 0.05; **p < 0.01; ***p < 0.001
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M concentration (A2058: 90.6  %, p  <  0.001; HT168-
M1: 87.0  %, p  <  0.001); however, the purpurin showed 
a lower activity after 6  h treatment compared to its 
72  h-long effect (A2058: Inh. Ind.6h  =  90.6  % vs. Inh. 
Ind.72h = 64.1 %; HT168-M1: Inh. Ind.6h = 87.0 % vs. Inh. 
Ind.72h = 76.2 %). The purpurin had no influence on the 
proliferation of MRC-5 cells.
In case of the aqueous extract, a growth inhibitory 
effect was observed only in A2058 cells (10−6 M: 93.3 %, 
p < 0.05; 10−5 M: 84.5 %, p < 0.001), but this effect was 
less pronounced than its long-term activity (10−6–10−5 
M: Ind.6h = 93.3–84.5 % vs. Inh. Ind.72h = 87.4–55.0 %). 
The extract had a slight, but significant proliferation 
inducer activity for HT168-M1cells (10−5 M: 116.1  %, 
p < 0.001) and a neutral effect for MRC-5.
Apoptotic effects
The apoptotic effect of alizarin, purpurin and the aqueous 
extract was analyzed by flow cytometry using annexin 
V-FITC labeling. The compounds were applied in 10−5 
M for 72 h, since in most of the cases, this concentration 
and incubation time displayed the highest antiprolifera-
tive/cytotoxic effect.
The alizarin and the purpurin failed to exert apoptotic 
effect in all model cells (Fig. 5). Nearly the same ratio of 
apoptotic melanoma cells was detected in the alizarin 
(A2058: 14.9 %; HT168-M1: 17.8 %) or purpurin (A2058: 
14.8 %; HT168-M1: 17.5 %) treated groups than in case of 
the methanol-treated control population (A2058: 15.4 %; 
HT168-M1: 18.6  %). While, both compounds slightly 
decreased the percentage of the apoptotic MRC-5 cells 
(alizarin: 26.7  %, purpurin: 26.8  %) comparing to the 
identical control (36.0  %) (Fig.  5). The aqueous extract 
exhibited an opposite profile; it proved to be less apop-
totic for the melanoma cells (A2058: 10.8  %, p  <  0.05; 
HT168-M1: 13.1  %, p  <  0.05) comparing to the control 
(A2058: 13.7 %; HT168-M1: 18.3 %) and had no effect on 
the number of the annexin V positive MRC-5 cells (30.6 
vs. 31.2 %) (Fig. 5).
Cell adhesion modulator properties
The cell adhesion curves of our model cells display dif-
ferent cell type specific shapes, but in all cases three 
main phases of the adhesion kinetic can be differenti-
ated. The initial phase (first 3 h after the cell inoculation) 
is the rapid adhesion characterized by a steep increase 
in the Cell index (CI) values. In the following phase 
(Δt ~ 3–20 h) the spreading of the cells accompanied by a 
slower, gradual increasing tendency of CI values. In long 
term (after 20–25 h) due to the cell proliferation a greater 
CI change can be observed (Additional file 1: Figure S2).
The adhesion of the cells and the effects of the anth-
raquinones on it were described by the slope of Delta CI 
calculated for a 3 h’ time interval (Table 2).
In a separate experiment with xCELLigence System, 
the growth rate of the melanoma cells were monitored for 
at least 72 h after inoculating 104 cells/well. The growth 
curves showed that both melanoma cell lines were in 
log phase. The detected CI parameter was continuously 
increased as the melanoma cell number was increased 
over the time (Additional file 1: Figure S3). Based on the 
growth curves of A2058 and HT168-M1 cells, 33 and 
27  h doubling times were calculated by RTCA 1.2 soft-
ware of the xCELLigence SP (Additional file 1: Figure S3).
Neither the pure anthraquinones nor the aqueous 
extract had any significant influence on the cell adhesion 
of melanoma cells; however a clear positive tendency 
can be observed in case of pure compounds. The alizarin 
in 10−6 M (A2058: 110.8 %; HT168-M1: 110.4 %), while 
the purpurin in 10−5 M (A2058: 115.6  %; HT168-M1: 
110.2 %) slightly induced the adhesion of both melanoma 
cells with nearly the same activity. In case of MRC-5 
fibroblasts only the purpurin had a weak, not significant, 
positive effect on cell attachment in 10−6 M (109.6  %) 
Table 1 Short term growth inhibitory effects of alizarin, purpurin and aqueous extract
Two different melanoma cell lines (A2058 and HT168-M1) and normal fibroblast cells (MRC-5) were applied as model cells and were incubated with the 
anthraquinones for 6 h
The ‘Inhibition index’ is expressed as a percentage of the control. Data shown in the table represent mathematical averages of six parallels and ± S.D. values
The level of significance is shown as follows: * p < 0.05; *** p < 0.001
Compound Conc. [M] Inhibition indexa (%) (control = 100 %)
A2058 HT168-M1 MRC-5
Alizarin 10−6 98.3 ± 1.52 98.3 ± 1.46 98.4 ± 1.62
10−5 103.8 ± 1.30 96.5 ± 1.61 104.6 ± 1.86
Purpurin 10−6 100.0 ± 1.45 100.8 ± 1.55 99.1 ± 1.12
10−5 90.6*** ± 1.09 87.0*** ± 1.79 103.16 ± 2.14
Aqueous extract 10−6 93.3* ± 0.86 101.9 ± 1.24 102.7 ± 1.52
10−5 84.5*** ± 1.06 116.1*** ± 1.39 100.3 ± 1.17
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(Table  2). The aqueous extract elicited a slight, but sig-
nificant decreasing effect (10−5 M: 91.7  %, p  <  0.05) on 
MRC-5 adhesion (Table 2).
Chemotactic effects
The comparison of chemotactic response of our model 
cells induced by the pure anthraquinones and the aque-
ous extract is shown on Fig. 6.
Both of the alizarin and purpurin elicited chemorepel-
lent responses in both melanoma cell lines; however, in 
different concentration range. The chemorepellence of 
alizarin was observed in 10−6–10−5 M concentrations 
(79.3–76.4 %, p < 0.05 and p < 0.001, respectively) in case 
of A2058 cells, and in 10−7–10−5 M for HT168-M1 cells 
(89.6–81.9  %, p  <  0.05) (Fig.  6a). The purpurin induced 
negative chemotactic responses of HT168-M1 in 10−7 M 
(78.6 %) in A2058 cells, and in 10−5 M (74.8 %) (Fig. 6b). 
In MRC-5 cells the alizarin also proved to be significantly 
repellent in 10−7 M (78.9 %, p < 0.01) (Fig. 6a), while the 
purpurin was neutral in the entire concentration range 
(Fig. 6b).
The aqueous extract had chemorepellent effect only in 
HT168-M1 cells both at 10−6 M and 10−8 M concentra-
tions (79.5 %, p < 0.05 and 73.6 %, p < 0.01, respectively), 
while in case of A2058 and MRC-5 it elicited no chemot-
actic effect (Fig. 6c).
Chemokinetic effects
Cell-tracking experiments accomplished by holo-
graphic microscopy represent a dedicated way to analyze 
chemokinetic activities in complexity of cellular migra-
tory responsiveness. The analyzed four parameters (‘Avg. 
Migration’, ‘Avg. Motility’, ‘Avg. Migration directness’ and 
‘Avg. Motility speed’) present information about the most 
important, chief characteristics (distance, orientation 
and speed) of cellular locomotion. As the time-frame of 
experiments was rather wide (2 h) our goal was to evalu-
ate not only the above mentioned parameters but also 
test whether the slopes of the corresponding graphs show 
any changes by the time.
Our results show that the both alizarin and purpu-
rin (both substances were tested in the optimal 10−5 M 
concentration) had significantly positive, cell locomotor 
inducer effects in both melanoma cell lines (Tables  3, 
4). Only ‘Avg. Migration directness’ (migration/motility) 
failed to fit to the trend in the case of alizarin in A2058 
cells. Values of slopes had no such a general and con-
cordant relation to the migratory responses. This means 
that while good correlations were observed between 
the alizarin and purpurin induced migratory responses 
(e.g. purpurin—‘Avg. Migration’, ‘Avg. Migration direct-
ness’ ‘Avg. Motility’; alizarin—‘Avg. Motility’, ‘Avg. Motil-
ity speed’) and their positive slope trends in A2058 cells 
(Table 3), no such clear positive slope trend was observed 
in HT168-M1 cells (Table 4).
Morphometry
Holographic microscopy detects morphological charac-
teristics of cells with high sensitivity and contributes to 
distinguish cytotoxic and apoptotic processes. The availa-
ble parameters calculated are grouped as basic (‘Avg. Area’, 
Fig. 5 Apoptotic effects of alizarin, purpurin and aqueous extract. 
Two different melanoma cell lines (A2058 and HT168-M1) and 
normal fibroblast cells (MRC-5) were applied as model cells and were 
incubated with the anthraquinones (10−5 M) for 72 h. The ‘Ratio of 
apoptotic cells’ is expressed as a percentage of viable cells measured 
by flow cytometry. Data shown in the figure represent mathematical 
averages of two parallels and ± S.D. values. The level of significance is 
shown as follows: *p < 0.05
Table 2 Adhesion modulator effect of the alizarin, purpu-
rin and the aqueous extract
Two different melanoma cell lines (HT168-M1) and normal fibroblast cells (MRC-
5) were applied as model cells
Data shown in the table represent mathematical averages of three parallels 
and ± S.D. values
The level of significance is shown as follows: * p < 0.05
a The slope values are expressed in percentage of the control and describe the 
changing rate of Delta CI in first 3 h’ time interval of cell adhesion
Compound Conc. [M] Slopea (%) (control = 100 %)
A2058 HT168-M1 MRC-5
Alizarin 10−8 88.9 ± 6.74 100.4 ± 3.05 99.3 ± 4.96
10−7 100.6 ± 4.01 104.3 ± 3.16 104.7 ± 0.82
10−6 110.8 ± 6.38 110.4 ± 1.37 100.2 ± 2.44
10−5 90.4 ± 8.7 107.3 ± 6.51 95.5 ± 7.08
Purpurin 10−8 85.6 ± 4.36 93.6 ± 4.91 102.1 ± 5.44
10−7 97.6 ± 1.86 101.0 ± 3.42 103.7 ± 2.22
10−6 95.2 ± 14.01 97.8 ± 15.16 109.6 ± 2.4
10−5 115.6 ± 6.56 110.2 ± 4.03 93.8 ± 5.14
Aqueous extract 10−8 99.3 ± 4.96 102.1 ± 5.44 105.4 ± 1.64
10−7 104.7 ± 0.82 103.7 ± 2.22 104.5 ± 1.99
10−6 100.2 ± 2.44 109.6 ± 2.4 98.4 ± 4.25
10−5 95.5 ± 7.08 93.8 ± 5.14 91.7* ± 2.58
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‘Avg. Thickness’, ‘Avg. Volume’) and complex (derived) 
ones (see the list and definitions in Sect. “Methods”).
Results showed that no basic parameter was influ-
enced by alizarin or purpurin as a cytotoxic or apoptotic 
substance in HT168-M1 cells. Moreover, in the case of 
A2058 cells alizarin could induce positive effects even 
in two variables (‘Avg. Area’ and ‘Avg. Volume’). Never-
theless, in the case of complex parameters A2058 cells 
proved to be more sensitive as significant decreases were 
detected in slopes of variables ‘Avg. Eccentricity’ and 
‘Avg. Hull convexity’ (the later parameter was also signifi-
cantly decreased in purpurin treated group, too) (Addi-
tional file 2: Tables S1–S4).
Discussion
In the present study the alizarin, purpurin and the aque-
ous extract were investigated in terms of selective activity 
on proliferation, cell adhesion and migration of tumor—
melanoma—cells. On the other hand the composition 
of the aqueous extract was analyzed and the molecular 
structure of the anthraquinones was evaluated with the 
aim to find an antitumor compound, which has a suitable 
functional group for using it as an effective compound in 
conjugate(s) of drug targeting.
Determination of constituents of the aqueous extract
In our study the method of hydrolysis by endogenous 
enzymes developed by Derksen et  al. was used to pre-
pare an extraction of Rubia tinctorum L. hairy root cul-
ture. They could detect pseudopurpurin, munjistin, 
alizarin and nordamnacanthal in the plant suspension 
[6]. In this study, the qualitative analysis of the extract 
was performed by LC–MS/MS method. The munjis-
tin (1,3-dihydroxyanthraquinone-2-carboxylic acid) 
was identified as the main component. In addition, 
the detailed analysis of the extract led to the identifica-
tion of three minor anthraquinones: pseudopurpurin 
(1,2,4-trihydroxyanthraquinone-3-carboxyl acid), rubia-
din (1,3-dihydroxy-2-methylanthraquinone) and nor-
damnacanthal (1,3-dihydroxyanthraquinone-2-al).
The main water soluble anthraquinones in mad-
der roots are the glycosides (ruberythric acid and luci-
din primeveroside) and the anthraquinone carboxylic 
acids (munjistin and pseudopurpurin). Similarly to the 
above mentioned study, our aqueous extract—as it was 
expected—did not contain the mutagenic lucidin pri-
meveroside or lucidin. The glycosides can be easily 
hydrolyzed by endogenous enzymes to their aglycons 
(alizarin and lucidin), after which, for example lucidin 
can be further converted to non-genotoxic nordamna-
canthal. The alizarin and nordamnacanthal are insoluble 
in water, which could explain why the alizarin was not 
found and only in small amount of nordamnacanthal was 
detected in our aqueous extract. In contrary, Derksen 
and co-workers could identify the alizarin and nordamn-
acanthal as the main components of the extract, but their 
extraction method was different as that was used in the 
present study. The initial extraction with distilled water 
was followed by addition of tetryhydrofuran-water-for-
mic acid solution to dissolve the precipitated anthraqui-
none agclycons. The different durations of extraction 
(45 or 90 min vs. 24 h) might also result in suspensions 
containing different anthraquinone derivatives or diverse 
ratios of these molecules [5, 6]. For example, the rubia-
din in our extract might be also converted from lucidin 
by endogenous enzymes as a result of longer stirring [22].
Tumor growth inhibitory effects of the alizarin, purpurin 
and aqueous extract
In our experiments on metastatic melanoma cell lines the 
alizarin and purpurin were included as representatives of 
Rubia-derived dihydroxy- and trihydroxyanthraquinones. 
In contrast to the previous results obtained with colon- 
[23], breast carcinoma and osteosarcoma cell lines [2], in 
Fig. 6 Chemotactic characters of the a alizarin, b purpurin and the c aqueous extract. Two different melanoma cell lines (A2058 and HT168-M1) 
and normal fibroblast cells (MRC-5) were applied as model cells. The ‘Chemotaxis index’ (Chtx. ind.) is expressed as a percentage of the control. Data 
shown in the figure represent mathematical averages of eight parallels and ± S.D. values. The level of significance is shown as follows: *p < 0.05; 
**p < 0.01; ***p < 0.001
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our study the alizarin did not have any antiproliferative 
or cytotoxic effect in melanoma cells. It was suggested 
that depending on the tumor type (osteosarcoma vs. 
prostate carcinoma cell line) the alizarin might exert anti-
tumor actions with different effectiveness [2]. The anti-
proliferative activity of the anthraquinones has been also 
shown to be determined by the number of OH groups. 
The compounds with more OH group were reported to 
be more effective [23]. Our results on melanoma cells—
the neutral effect of dihydroxyanthraquinone alizarin and 
the tumor growth inhibitory activity of the purpurin (tri-
hydroxyanthraquinone)—are in good agreement with the 
findings cited above.
In our present study the aqueous extract proved to 
be the most effective antiproliferative/cytotoxic agent 
in melanoma cells. Limited data are available in the lit-
erature about the antiproliferative or cytotoxic effects of 
the anthraquinones which were identified in this extract. 
Few studies have demonstrated that the nordamnacan-
thal or its analogue (damnacanthal) inhibited the prolif-
eration of various cell lines [24, 25]. Although, there is 
no information about the direct tumor growth inhibitory 
action of rubiadin but its significant phototoxicity has 
been observed in a breast cancer cell line [26]. The more 
potent antitumor activity of the extract in equimolar con-
centration than the pure anthraquinone compounds can 
be explained (1) by the possible additive actions of rec-
ognized anthraquinones, or (2) by other unknown minor 
compounds of the extract.
The MTT assay, which was used to determine the 
tumor inhibitory effect of the anthraquinone com-
pounds, could provide information about the number of 
the viable cells by detecting the NADH-dependent dehy-
drogenase activity, but not about the form of cell death. 
In order to explore the mechanism of their antitumor 
effects, an apoptosis measurement was carried out. It 
was shown that anthraquinones failed to induce apopto-
sis, so their antitumor effects were mediated by unknown 
mechanisms (e.g. altering the cell cycle [2]) rather than 
inducing apoptosis.
In most of the cases it took at least 48 h for the anth-
raquinones to exert their significant antitumor activity 
on melanoma cells and this activity became even more 
pronounced for 72  h. This lag in their effect could be 
Table 3 Migratory behavior of A2058 melanoma cells detected by holographic microscopy
Effect of treatment with alizarin (10−5  M) and purpurin (10−5 M)
Data shown in the table represent variables and ± S.D. values calculated for 50 cell/group in 240 consecutive frames
The ‘Mean’ values are expressed as dimensions (μm, μm/h) shown in the sub-headers of the table
The slope values are expressed as dimensionless values to describe the changing rate of Mean values in the 2 h’ time interval of treatments
R and Adj. R-Square represent data of linear regression analysis to describe trends of variables belonging to the parameters calculated
The level of significance is shown as follows: * p < 0.05; ** p < 0.01; *** p < 0.001
A2058 Methanol Alizarin (10−5 M) Purpurin (10−5 M)
Avg. Migration (μm)
 Mean 5.347 ± 0.16 8.719 ± 0.25** 22.667 ± 0.82***
 Slope 0.034 ± 6.82E−4 0.056 ± 7.03E−4 0.170 ± 0.01***
 R 0.955 0.981 0.933
 Adj. R-square 0.912 0.963 0.870
Avg. migration directness (migration vs motility)
 Mean 0.110 ± 0.01 0.100 ± 0.01 0.196 ± 0.01**
 Slope −6.40E−4 ± 7.83E−5 −7.14E−4 ± 8.38E−5 −2.30E−4 ± 6.79E−5**
 R 0.468 0.482 0.214
 Adj. R-square 0.215 0.229 0.042
Avg. motility (µm)
 Mean 75.229 ± 2.63 125.627 ± 4.94** 104.172 ± 3.99*
 Slope 0.587 ± 0.01 1.099 ± 0.01*** 0.890 ± 0.01**
 R 0.998 0.997 0.998
 Adj. R-square 0.996 0.995 0.996
Avg. motility speed (µm/h)
 Mean 79.931 ± 1.14 134.900 ± 2.44** 104.630 ± 4.75*
 Slope 0.063 ± 0.01 0.279 ± 0.03*** 0.045 ± 0.06
 R 0.248 0.514 0.042
 Adj. R-Square 0.057 0.261 0.002
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explained by the cell cycle length (A2058: 33 h; HT168-
M1: 27 h) and the non-synchronous division of the mela-
noma cells. Although, the A2058 cell line exhibits lower 
proliferation rate and metastatic capacity [27] than the 
HT168-M1 cell line, the A2058 cells appeared to be more 
sensitive toward the long-term antiproliferative/cyto-
toxic effects of purpurin and aqueous extract than the 
HT168-M1 cells. So other factors, like the confluence of 
the cell culture, or cellular uptake of the anthraquinones 
were also taken into consideration. It was reported that 
efficacy of a chemotherapeutic agent on tumor growth 
highly depends on the confluence or the phases of cell 
growth. For example, anthracyclines (e.g. doxorubicin) 
had lower cytotoxic activity in cells of stationary growth 
phase compared with exponentially growing cells [28]. 
As it was demonstrated in a real time measurement, the 
cells were in a logarithmic growth phase during 72  h. 
The anthraquinone-resistance induced by the noncycling 
state (stationary phase) of cells could be excluded. Never-
theless, the antitumor efficacy of the anthraquinones in 
stationary, no- or slowly growing cells would be interest-
ing to investigate. The efficacy of the chemotherapeutic 
drugs in noncycling cells basically depends on the mech-
anism of their effect, which is still an open question in 
case of the Rubia-derived anthraquinones.
Regarding the internalization of the anthraquinones it 
was found that, less than 10 % of melanoma cells could 
internalize the alizarin after 72  h long incubation time. 
However, the cellular uptake of purpurin was higher, but 
only about 60 % of melanoma cells were “anthraquinone 
positive” (Additional file 1: Figure S4). The difference in 
the efficacy of the compounds could be also determined 
by their internalization. The increased cellular uptake 
seemed to enhance the anti-tumor activity. The order of 
the internalization rate and the antitumor activity of the 
compounds was the same: alizarin ≪ purpurin < aqueous 
extract.
However, the tumor growth inhibitory effect of long-
term treatment manifested after 48  h, the washing out 
of the anthraquinones after 6 h-long exposure could still 
cause a slighter but significant antiproliferative effect. 
This means that the effect of the compounds appeared to 
be irreversible for melanoma cells.
Table 4 Migratory behavior of HT168-M1 melanoma cells detected by holographic microscopy
Effect of treatment with alizarin (10−5  M) and purpurin (10−5 M)
Data shown in the table represent variables and ± S.D. values calculated for 50 cell/group in 240 consecutive frames
The ‘Mean’ values are expressed as dimensions (μm, μm/h) shown in the sub-headers of the table
The slope values are expressed as dimensionless values to describe the changing rate of Mean values in the 2 h’ time interval of treatments
R and Adj. R-Square represent data of linear regression analysis to describe trends of variables belonging to the parameters calculated
The level of significance is shown as follows: * p < 0.05; ** p < 0.01; *** p < 0.001
HT168-M1 Methanol Alizarin (10−5 M) Purpurin (10−5 M)
Avg. Migration (μm)
 Mean 8.870 ± 3.65 26.651 ± 10.65*** 15.490 ± 6.14***
 Slope 0.052 ± 4.54E−4 0.140 ± 0.01 0.086 ± 0.01
 R 0.991 0.920 0.976
 Adj. R-square 0.982 0.846 0.953
Avg. migration directness (migration vs. motility)
 Mean 0.127 ± 0.01 0.189 ± 0.01** 0.146 ± 0.01
 Slope 6.55E−4 ± 8.10E−5 8.23E−4 ± 7.26E−5 7.52E−4 ± 7.89E−5
 R 0.464 0.524 0.464
 Adj. R-square 0.212 0.346 0.272
Avg. motility (µm)
 Mean 96.346 ± 3.49 184.515 ± 7.38*** 118.951 ± 4.21*
 Slope 0.778 ± 0.01 1.643 ± 0.01 0.937 ± 0.01
 R 0.998 0.999 0.997
 Adj. R-square 0.997 0.998 0.997
Avg. motility speed (µm/h)
 Mean 96.609 ± 1.46 188.513 ± 3.94*** 115.551 ± 2.05
 Slope 0.056 ± 0.02 0.199 ± 0.05 0.033 ± 0.03
 R 0.172 0.227 0.074
 Adj. R-square 0.025 0.047 0.001
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Activities of alizarin, purpurin and aqueous extract on the 
cell adhesion and migration
The metastatic spreading of tumor cells from the pri-
mary site is a crucial aspect of tumor progression and 
can significantly affect the effectiveness of the targeted 
tumor therapy. The altered cell adhesion and migration of 
tumor cells are critical for the tumor cells to invade the 
surrounding tissues, to migrate into a distant site and to 
attach and form a new colony [29].
Although the Rubia-derived anthraquinones could 
not have significant cell adhesion modulator effect, they 
could interfere with the migration of metastatic mela-
noma cells. Both of the pure anthraquinones induced the 
repellent responses of both A2058 and HT168-M1. Our 
present results are in harmony with a study on the indi-
rect blocking effect of purpurin in LTB4 induced chemot-
actic reaction of CHO cells [11].
Characterization of anticancer substances requires a 
detailed analysis of cell physiological responses in their 
complexity. Locomotor activity and alteration of mor-
phological parameters are considered as chief tumor spe-
cific features to be investigated as prognostic markers of 
the candidate drugs. In our present work both alizarin 
and purpurin proved to possess characteristic chemore-
pellent effects as well as chemokinesis enhancer charac-
ters as both length of tracks (‘Avg. Migration’ and ‘Avg. 
Motility’) and speed of migrating cells were increased by 
the treatments. The complex analysis of migratory behav-
ior shows that application of the two compounds is more 
advantageous as they potentially facilitate cell accumula-
tion in primary tumors and not spreading as metastatic 
ones. In respect of morphometry—despite the fact that 
a number of parameters were examined—our results are 
more moderate. Nevertheless, the data obtained support 
our conclusion detailed before that the two anthraqui-
none derivatives have no significant apoptotic effects in 
the backgrounds of their cytotoxicity.
Evaluation of the suitability of anthraquinones for targeted 
tumor therapy
Investigation of the toxic effect of anthraquinones on 
the normal cells is also an important issue regarding the 
design of the targeted therapy. This consideration justi-
fies that MRC-5 normal human fibroblast cells were also 
involved in our study. Notably, the normal fibroblasts 
proved to be more resistant to purpurin in all in  vitro 
assays, which suggests that purpurin has a selective tox-
icity and chemorepellence on melanoma cells. There was 
a good correlation between the uptake and the efficacy 
of purpurin obtained in melanoma and MRC-5 cells. In 
case of MRC-5 cells, the lower antiproliferative/cyto-
toxic activity of purpurin could be due to its low inter-
nalization rate, while the increased cellular uptake was 
associated with more pronounced antitumor activity 
in melanoma cells. Comparing the doubling times of 
the melanoma cells (A2058: 33 h; HT168-M1: 27 h) and 
MRC-5 cells (in publications rather different values were 
reported: 27  h [30], 34  h [31], 40  h [32]) there was not 
a significant difference, which could have explained the 
resistance of MRC-5 to purpurin. Nevertheless, such a 
remarkable difference in the cellular uptake of the pur-
purin by melanoma cells and MRC-5 cell line might 
suggest that the purpurin acts on a cell surface receptor 
expressed differently in tumor vs. normal cells.
This tumor selective activity of purpurin is underlined 
by the fact that other anthraquinones including emodin 
(trihydroxyanthraquinone) and mollugin (anthraquinone 
related compound) were reported to evoke a less or no 
cytotoxic effect in cells derived from normal breast tissue 
[33, 34].
In contrast to purpurin the growth inhibitory activ-
ity of aqueous extract was not selective to tumor cells; it 
reduced the cell number as well as the cell adhesion of 
normal fibroblasts. Some studies have reported that the 
rubiadin exerted strong genotoxicity as well as played a 
critical role as an initiator of carcinogenesis [35, 36]. It is 
possible that the non-selective damaging effect of aque-
ous extract is due to one of its genotoxic anthraquinone 
components. It is important to emphasize that the aliza-
rin and purpurin are free of this type of activity [19, 37], 
while no data have been found yet about the genotoxicity 
of munjistin, pseudopurpurin or nordamnacanthal in the 
literature.
Our results suggest that the purpurin can exhibit selec-
tive anticancer activity and by inducing chemorepellent 
migratory response of melanoma cells it can interfere 
with tumor progression. These results indicate that the 
purpurin might be developed as a targeted anticancer 
agent acting on melanoma cell specific molecular target.
Although, the aqueous extract failed to exert tumor 
selective activity but the identification of munjistin, pseu-
dopurpurin and nordamnacanthal might be promising 
agents for targeted therapy. Since these anthraquinone 
derivatives possess eligible moieties (carboxyl or alde-
hyde groups) they could be suitable candidates to be 
applied in drug delivery conjugates as an anticancer drug. 
Nevertheless, even more studies are required to verify 
the potential anticancer activity of the three individual 
anthraquinones composing aqueous extracts reported 
now as well as to exclude their genotoxicity.
Conclusions
In summary, we showed that the purpurin, a trihydroxy-
anthraquinone and an aqueous extract from transformed 
root culture of Rubia tinctorum L. had tumor growth 
inhibitory activity in melanoma cell lines with different 
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metastatic ability, and their effects proved to be irrevers-
ible and unrelated to apoptosis induction. The tested 
anthraquinones showed chemorepellent character and 
chemokinesis inducer effect in A2058 and HT168-M1 
melanoma cells. Furthermore, the purpurin elicited sig-
nificantly lower activity or neutral effect on proliferation 
and chemotaxis of normal fibroblast cells compared to 
the tumor model cells. These tumor selective properties 
of purpurin enable it to be used as targeted anticancer 
agent acting on a tumor cell specific molecular mecha-
nism. The detailed analysis of aqueous extract led to 
the identification of munjistin as the principal compo-
nent and three minor anthraquinones (pseudopurpurin, 
rubiadin, and nordamnacanthal). Based on the cytotoxic 
effect of the aqueous extract and the identification of 
anthraquinone derivatives possessing suitable moieties 
for coupling them to a peptide type targeting unit, our 
present results suggest the application of these anth-




Plant material: hairy root culture
The seeds of Rubia tinctorum L. were originated from 
VILAR Botanical Garden, Moscow. Transformed root 
cultures of Rubia tinctorum L. were obtained by their 
inoculation with Agrobacterium rhizogenes (strain 
R-1601). The hairy roots were cultured in liquid Gam-
borg B5 medium [38, 39] in Erlenmeyer flasks, in a Cer-
tomat BS-4 programmable incubation shaking cabinet 
(Braun Biotech International, Melsungen, Germany) at 
100 rpm, under 23 ± 2 °C, in the dark.
Test substances
The tested substances were (1) pure anthraquinone com-
pounds: alizarin (1,2-dihydroxy-9,10-anthraquinone) 
(Fig.  1a) and purpurin (1,2,4-trihydroxy-9,10-anth-
raquinone) (Fig. 1b) (Irvine, CA, USA) and (2) an aque-
ous extract of sample of Rubia tinctorum L. hairy root 
culture.
The purpurin and alizarin were solved in methanol 
to prepare the stock solution (2 ×  10−3 M). Serial dilu-
tion ranged from 10−8 to 10−5 M were prepared from 
the stock in complete cell culture medium of each model 
cells. Each dilution has a control, where the identical ratio 
of methanol solved in complete cell culture medium.
The total concentration of anthraquinones of aqueous 
extract was expressed as a relative concentration cor-
related to the concentration of standard purpurin. The 
aqueous extract was further diluted to equimolar con-
centration (10−8–10−5 M) of pure anthraquinones in 
complete cell culture medium.
Phytochemical analysis
Preparation of extract
Lyophilized (Christ Alpha 1-4 lyophilizator, Braun, 
Melsungen, Germany), and powdered material (100 mg) 
obtained from Rubia tinctorum L. hairy root culture was 
extracted with 50  ml of ultrapure water (purified with 
Millipore (Billerica, MA, USA) Direct-Q5 equipment) by 
stirring (100 rpm) overnight at room temperature.
Purification of extract
After filtration, 5 ml of the extract was passed drop-wise 
through solid phase extraction (SPE) cartridges (Supel-
clean LC-8, 3  ml; Supelco, Bellefonte, PA, USA) previ-
ously activated with methanol (5 ml) then water (5 ml). 
The fraction containing the anthraquinones was eluted 
from the cartridges with 2.5 ml of methanol.
Qualitative determination by LC–MS/MS
Compounds were separated on a LUNA octyl (5  μm) 
reversed phase column (250 × 4.6 mm I.D.; Phenomenex, 
Torrance, CA, USA). The column temperature was 25 °C 
and the injection volume 10 µl. The mobile phase was a 
linear gradient of acetonitrile—20  mM ammonium for-
mate (pH 3.0) 15 → 100 (v/v). The flow-rate was 1 mL/
min. Analysis was performed in negative ion mode on 
an Agilent 6410 Triple Quad LC/MS system using elec-
trospray ionization. The injection volume was 10 μL. By 
solvent splitting, 40  % eluent was allowed to flow into 
the mass spectrometer. The conditions of the LC–MS/
MS analysis were as follows: drying gas (N2) temperature 
350  °C, drying gas flow rate 9 l/min, nebulizer pressure 
45.0 psi (N2), fragmentor voltage 120 V, capillary voltage 
4000 V, scan range from m/z 50 to 700 at collision energy 
of 15 or 20 eV depending on the molecular structure.
Analysis of cell biological activities
Model cells
The effects of the Rubia-derived anthraquinones were 
evaluated in A2058 and HT168-M1 human melanoma 
cell lines with different metastatic potency. A2058 cells 
derived from a brain metastases shows high metastatic 
capacity [40]. HT168-M1 line is an in vivo selected, more 
metastatic derivative of A2058 [41]. The MRC-5 normal 
fibroblast cells derived from normal lung tissue were 
used as control [42].
Cultures of A2058 and HT168-M1 were maintained in 
RPMI 1640 (Sigma Ltd. St. Louis, MO, USA) containing 
10 % FCS (Lonza Group Ltd., Switzerland), l-glutamine 
(2  mM), 100  µg/ml penicillin/streptomycin (Gibco®/
Invitrogen Corporation, New York, NY, USA) and the 
MRC-5 cells with generation number between 18 and 20 
were cultured in DMEM (Sigma Ltd. St. Louis, MO, USA) 
containing 10  % FCS (Lonza Group Ltd., Switzerland), 
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l-glutamine (2  mM), 100  µg/ml penicillin/streptomycin 
(Gibco®/Invitrogen Corporation, New York, NY, USA) 
and 1  % non-essential amino acids (Gibco®/Invitrogen 
Corporation, New York, NY, USA) at 37 °C in a humidi-
fied 5 % CO2 atmosphere.
Cytotoxicity analysis
The long term antiproliferative/cytotoxic effects of anth-
raquinones and aqueous extract were determined by 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide assay (MTT assay).
After seeding the cells (104 cells/well) on 96-well plates 
and culturing them for 24 h, the cells were treated with 
substances using 10−8–10−5 M concentration range. 
After 48  h and 72  h incubation time the MTT (3-(4,5 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium; Sigma 
Ltd., St. Louis, MO, USA) solution was added to each 
sample at 0.5 mg/ml final concentration.
After 4  h incubation with the MTT reagent the cul-
ture medium was removed and the reaction products, 
formazan crystals were dissolved in 100 μL dimethyl 
sulfoxide (DMSO). The optical density (OD) of the 
formazan solution was measured at 540 nm (OD540) and 
620 nm (OD620) by ELISA reader (Labsystems Multiskan 
MS, Helsinki, Finland).
In order to evaluate whether the compounds have 
reversible antiproliferative/cytotoxic character the anth-
raquinones were removed from the cells after 6  h of 
incubation. The cells were washed twice with serum-free 
medium and cultured for a further 72  h in the serum-
containing medium [43]. After this cell culturing period 
the MTT assay was carried out as described above.
Identical points of the concentration course study rep-
resent average of 6 parallel measurements. The decrease 
in the number of cells due to the anthraquinones (A) was 
normalized to the identical control (Ctrl) and this value 
was given as ‘Inhibition index’ (Inh. ind.) in percent.
Apoptosis assay
The apoptotic effect of the anthraquinones and the aque-
ous extract on our model cells was measured by FACS-
Calibur flow cytometer (Becton–Dickinson, San Jose, 
CA, USA) after staining with annexin V-FITC (Becton–
Dickinson, San Jose, CA, USA).
Prior the treatment with the compounds, the cells 
were seeded on 12-well plates in 105 cells/well density 
and cultured for 24 h. The compounds were added to the 
cells in 10−5 M concentration and the incubation time 
was 72 h (as in case of the long term cytotoxicity analy-
sis). For the annexin V-staining the supernatant were 
removed and TrypLE reagent composed of recombinant 
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cell-dissociation promoting enzymes (Thermo Fisher Sci-
entific, Waltham, MA, USA) was added to the cells. The 
effect of the TypLE was stopped after 3  min by adding 
fresh serum-containing cell culture medium. The cells 
were transferred to FACS-tubes and after a centrifuga-
tion and a washing step with PBS (phosphate-buffered 
saline pH  =  7.2) the annexin binding buffer (Becton–
Dickinson, San Jose, CA, USA) was added to resuspend 
the cells. Before labeling with annexin V-FITC, the cells 
were measured by a flow cytometer for controlling the 
autofluorescence of the cells in case of each treatment 
group. Then, the cells were labeled with annexin V-FITC 
for 15  min in dark and analyzed by a flow cytometer 
using 10,000 cells for each measurement. As dead cells 
lose their membrane integrity, forward and side scatter 
values (FS/SS in dot plot) were used to exclude debris 
and dead cells. For the measurement and analysis of data 
CellQuest Pro software was used. For the numerical com-
parison, the detected values (FL1 detector) of the annexin 
V-labeled, viable cells were adjusted with non-labeled 
samples and the percentage of the annexin positive cells 
in the treated groups was compared to the percentage of 
the annexin positive control cells.
The apoptosis assay, carried out by flow cytometry, pro-
vided the opportunity to determine the cellular uptake of 
the anthraquinones having fluorescence property. The 
intracellular fluorescence intensity of the model cells 
treated with the compounds could be quantified by FL2 
detector of FACSCalibur flow cytometer and the values 
were compared to autofluorescence of the non-treated 
controls.
Cell adhesion assay
The effect of the anthraquinones and the aqueous extract 
on cell adhesion of the model cells were assessed using 
the xCELLigence SP System (Roche Applied Science, 
Indianapolis, IN, USA). This system allows monitoring 
the cellular events by measuring electrical impedance in 
real time manner across gold microelectrodes integrated 
on the bottom of tissue culture plate, so called E-plate. 
The detected impedance change depends on the num-
ber or the spreading of cells attached to the surface of 
the electrodes. The change in impedance is represented 
as Cell Index (CI). The CI is a relative and dimensionless 
value, and calculated by the following formula:
where Zi is the impedance at an individual point of time 
during the experiment, Z0 is the impedance at the start 
of the experiment, and Fi is a constant depending on the 
frequency (F10kHz = 15).
The impedimetric measurement was performed 
as previously reported [44]. The solutions of the 
(2)CI = (Zi − Z0)/Fi
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anthraquinones were added in the concentration range of 
10−8–10−5 M and 10,000 cells per well were seeded. The 
adhesion of our model cells was monitored in every 20 s 
for at least 12 h at 10 kHz.
The attachment and the spreading of our model cells 
was characterized by a time course study of the Delta CI 
values. The Delta CI refers to the difference of CI value at 
time point of cell inoculation and CI value at a given time 
point. The adhesion ability of the cells was described by 
the slope of Delta CI calculated for a 3  h time interval. 
The slope values were expressed in percentage of the con-
trol. The Delta CI and slope values were calculated by the 
integrated software (RTCA 1.2, Roche Applied Science, 
Indianapolis, IN, USA). Each data represents the math-
ematical average of three parallels.
Chemotaxis assay
Chemotactic responsiveness of the three cell lines was 
measured in a NeuroProbe® MBB 96 chamber (Neuro-
Probe, Gaithensburg, MD, USA) by using polycarbonate 
filters with pore size 8 μm. The substances were diluted 
in FCS-free cell culture medium to 10−8–10−5 M concen-
trations, except the aqueous extract, for which the final 
concentration range was 10−8–10−6 M. The incubation 
time was 24 h at 37  °C in a humidified 5 % CO2 atmos-
phere. The number of the positive chemotactic responder 
cells was determined by MTT assay as described above. 
Identical points of the concentration course study rep-
resent average of 8 parallel measurements. The evalu-
ated value was normalized to the control and this value is 
given as ‘Chemotaxis index’ (Chtx. ind.), in percent.
Holographic microscopy
The HoloMonitor™ M4 (Phase Holographic Imaging, 
Lund, Sweden) was used as an incubator proof, time-
lapse and cell tracking instrument for adherent cells. In 
this equipment development of image applies a non-
invasive technique—digital holography—that does not 
require any labeling or staining. The applied technique 
is based on how the target cells shift the phase light that 
passes through the cell. The image is reconstructed on 
the basis how the cells interfere with the light. The pro-
vided data characterize locomotor behavior of the cells as 
well as describe in vivo morphological alterations elicited 
by other cells or environmental factors. HoloStudio™ M4 
2.5 was used as dedicated software to capture and analyze 
series of images gained in time-lapse recording of cells.
Special considerations and limits arising from the spe-
cial technical features of holographic microscope in the 
present experiment: (1) as laser beam is applied to gen-
erate interference patterns we had to limit the tested 
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compounds to alizarin and purpurin as phototoxicity of 
some components of the aqueous extract is conceivable 
[26]; (2) development of holographic image is rather dif-
ficult and results poor image in some tenuous cell types 
(e.g. endothelium, fibroblast cells)—therefore in this part 
of the study only the two melanoma cell lines (A2058 and 
HT168-M1) were investigated but not MRC-5 cells.
Chemokinetic effects In the present experiments the 
chemokinetic effects were evaluated by holographic 
tracking, measurement and calculation of the following 
parameters: (1) migration—the shortest direct distance 
from the starting point to the end point (μm); (2) motil-
ity (μm)—the actual way traveled from the starting point 
to the end point (μm); (3) migration directness—ratio 
of migration and motility (dimensionless); (4) motility 
speed—the actual way traveled from the starting point to 
the end point given per hour (μm/h).
The procedure of measurement in brief:
The cells (2.5 × 105) were seeded on a Petri dish (diam-
eter: 35  mm) and cultured for 24  h prior the treatment 
with compounds in 10−5 M final concentration. Follow-
ing automatic and manual calibrations the proper field 
of the slide with cells was focused by autofocusing. In 
time-lapse tracking the settings were: total time =  2  h; 
interval  =  30  s. For evaluation of images of time-lapse 
automatic background thresholding method was used 
with “Minimum error sets” algorithm (adjustment = 128) 
using the minimum error histogram-based threshold 
method; in object definition, the minimum object size 
was 36. The number of evaluated cells/image: 50; the total 
number of evaluated images: 240. For manual cell iden-
tification, objects of the marginal zone were abandoned. 
Reliability of tracking was controlled according to human 
judgment frame-by-frame.
Morphometry Once the cell movement has been tracked, 
the cell morphology can also be followed over time by using 
the Plot Features tab. Different morphological parameters 
can be displayed. The list below contains all parameters 
calculated to characterize morphological changes of our 
tumor model cells (A2058 and HT168-M1). (1) Area—it 
is the surface area of the image that is occupied by the cell 
(μm2). The calculations are based on a threshold setting 
that distinguishes background from cell. (2) Thickness 
avg.—it is the average thickness of the cell (μm). The calcu-
lations are based on the phase shift, the wavelength of the 
light and the refractive index of the cell. (3) Volume— is the 
optical cell volume (μm3), it is based on values of ‘Area’ and 
‘Thickness’. (4) Roughness—it is calculated by subtracting 
a mathematically smoothed image from the actual image 
in each pixel, and gives an indication of the smoothness/
roughness of the cell. The calculations are based on the 
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phase shift in each pixel of the thresholded cell. A healthy 
cell has usually a low degree of roughness while a dying or 
dead cell usually has more roughness. (5) Eccentricity—it 
is how elongated the cell is, or how much the cell deviates 
from being a circle. A value of 0 corresponds to a circle and 
the more elongated the cell is the higher the eccentricity 
value becomes, approaching 1. The calculations are based 
on a threshold setting that distinguishes background from 
cell. (6) Hull convexity—it is a measure on how much the 
3D cell shape deviates from the perfect convex shape. A 
cell is usually rather smooth in 3D, a higher value means 
less dips in cell thickness, i.e. a more perfect shape. (7) 
Irregularity—it is a measure of how much the circumfer-
ence of the cell deviates from the circumference of a per-
fect circle. A value of 0 means the cell is circular and higher 
values mean a longer, more irregular outline. The calcula-
tions are based on a threshold setting that distinguishes 
background from cell [45].
Statistical evaluation of data
Data obtained from each experiment represent aver-
ages  ±  S.D. values and were expressed as a percent of 
the control. Statistical analysis was performed using the 
one-way ANOVA algorithm of Origin Pro 8.0 (Origin-
Lab Corporation, Northampton, MA, USA) program. In 
holographic microscopy HoloStudio™ M4 2.5 program 
was used to analyze data.
Significance levels correspond to *p < 0.05; **p < 0.01; 
***p < 0.001.
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